Molecular mechanisms of bone metastasis and therapeutic implications.
about
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasionImpaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitorsInhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.Chemotherapy resistance in osteosarcoma: current challenges and future directions.Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.Targeted prodrug approaches for hormone refractory prostate cancer.A Case of Carcinoid Tumor-Associated Hypercalcemia.Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.Hypercalcaemia caused by a carcinoid tumour.Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.
P2860
Q30447945-CE994F74-5675-4786-8CD2-13026A729B47Q33819359-8EC803C3-F24C-45FC-A235-0A6022ED4B60Q34732727-DED1AF38-1C71-427E-82D9-FB34191C48BAQ35366515-3CD6A1F4-6B3F-4714-9902-443B088B942AQ35688200-D8EA8304-839B-48C1-9FF2-F8BE1F866A25Q36532115-0C080D45-B828-4D32-849E-C9A0B9854E1BQ36731426-259BF7AA-6ADE-466F-93CE-AF62090FC2D1Q37218904-8E6BD210-DD4E-4C05-A4DD-EE3CE699E8E0Q37697815-3079F4B6-98D5-412F-A6C2-56CD6EA768CEQ38295983-D4DF7399-43E2-4BE9-855D-392CEF0839B2Q39249427-BBB056DB-F123-42D5-B263-229E9CA17253Q40228665-9D0E8C33-FD84-4C95-8FE5-2A45C6E02FBDQ45938294-20C925AD-8540-4266-8D66-769BF4D13FC3Q46972223-D70623D6-DE3C-42EE-B407-7FA9C03AF379Q52914491-73E4BFB9-B0A7-4237-BFF0-A888DAA7E7FA
P2860
Molecular mechanisms of bone metastasis and therapeutic implications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecular mechanisms of bone metastasis and therapeutic implications.
@ast
Molecular mechanisms of bone metastasis and therapeutic implications.
@en
type
label
Molecular mechanisms of bone metastasis and therapeutic implications.
@ast
Molecular mechanisms of bone metastasis and therapeutic implications.
@en
prefLabel
Molecular mechanisms of bone metastasis and therapeutic implications.
@ast
Molecular mechanisms of bone metastasis and therapeutic implications.
@en
P1476
Molecular mechanisms of bone metastasis and therapeutic implications.
@en
P2093
Regis J O'Keefe
P304
P356
10.1097/01.BLO.0000093847.72468.2F
P407
P433
P577
2003-10-01T00:00:00Z